The involvement of murine protein tyrosine phosphatase-PEST (MPTP ± PEST) in signal transduction pathways is suggested by its ability to dephosphorylate phosphotyrosine residues, its interaction with the adaptor protein SHC and by the presence of ®ve proline-rich stretches in its non-catalytic carboxyl terminus. Proline-rich sequences have been identi®ed as binding sites for Src homology 3 (SH3) domains found in proteins associated with signal transduction events. The ability of these sequences to act as SH3 domain recognition motifs was investigated using bacterially expressed SH3 domains derived from several dierent signalling proteins. In vitro binding assays indicate that four of these proline-rich sequences constitute speci®c binding sites for both SH3 domains of the adaptor molecule Grb2. Wild type Grb2, but not Grb2 proteins corresponding to loss-of-function mutants in the Caenorhabditis elegans sem-5 protein, associate with MPTP ± PEST in vivo. Experiments in EGF receptor expressing cells show that the interaction between MPTP ± PEST and Grb2 results in the binding of this complex to activated EGF receptors. In addition, identi®cation of putative substrate(s) of MPTP ± PEST have revealed a candidate protein of *120 kDa which is tyrosine phosphorylated upon EGF stimulation. Together, these results describe a novel SH3 domaindependent recruitment of a protein tyrosine phosphatase to an activated receptor tyrosine kinase and establish a potential role for MPTP ± PEST in signalling pathways at the molecular level.
Introduction
Src homology 2 (SH2) and Src homology 3 (SH3 1 ) domains are conserved structural motifs mediating protein-protein interactions between eector proteins that are responsible for transmitting various regulatory cascades from cell surface receptors (for review see Pawson, 1995) . These protein modules are often the unique constituents of a growing group of signal transduction proteins known as`adaptor' proteins which appear to function as`connectors', integrating several extracellular signals into multiple intracellular signalling pathways. One of the strongest evidence implicating adaptor molecules as critical components in signal transduction pathways arose from studies of the Grb2/Sem-5/Drk protein.
Grb2 is a ubiquitously expressed protein of 25 kDa that is composed of a single SH2 domain and twō anking SH3 domains. Grb2 is functionally and structurally homologous to the product of the C. elegans gene sem-5 (Clark et al., 1992; Stern et al., 1993) and to the Drosophila gene drk Simon et al., 1993) . Genetic and biochemical studies have demonstrated that one of the functions of Grb2 is to link tyrosine-phosphorylated receptors to Ras activation via the SH3 domain-mediated binding of Grb2 to Sos, a guanine nucleotide exchange factor for Ras (Buday and Downward, 1993; Clark et al., 1992; Egan et al., 1993; Gale et al., 1993; Li et al., 1993; Olivier et al., 1993; Rozakis-Adcock et al., 1993; Simon et al., 1993) . In addition to its role in the Ras signalling pathway, Grb2 appears to be involved in other pathways, including the regulation of membrane rues formation, possibly through its interaction with the cytoskeleton Matuoka et al., 1993) .
MPTP ± PEST is a ubiquitously expressed protein tyrosine phosphatase (PTPase) that is composed of a single NH 2 -terminal phosphatase domain and a noncatalytic COOH-terminal tail. The latter has been shown recently to interact with the phosphotyrosine binding (PTB) domain of the adaptor oncoprotein SHC in a phosphotyrosine-independent manner (Charest et al., 1996) thus implicating MPTP ± PEST in SHC mediated cellular functions. In addition to this SHC PTB domain binding site, the COOH-terminus of MPTP ± PEST contains several proline-rich sequences (Charest et al., 1995b) . Proline-rich motifs have recently been demonstrated to serve as binding sites for SH3 domains which are present in several signalling proteins Fantl et al., 1992; Lowenstein et al., 1992; Ren et al., 1993; Viguera et al., 1994) . Structural and binding studies using many dierent SH3 domains have led to the generation of models for SH3 domain-ligand interactions and to the characterization of two classes of SH3 domain binding sites. Class I sites display a R-X-X-P-X-X-P consensus sequence (single letter amino acid code, where X represents any amino acid residue) whereas class II sites consist of a P-X-X-P-X-R consensus sequence (for review see Mayer and Eck, 1995) .
In this report we demonstrate that the proline-rich sequences of MPTP ± PEST constitute speci®c binding sites for the SH3 domains of the adaptor protein Grb2. We also show that this SH3 domain-mediated interaction serves as the molecular basis for the recruitment of MPTP ± PEST to activated EGF receptors. Finally, we reveal the existence of a potential tyrosine phosphorylated substrate of 120 kDa for MPTP ± PEST. The data presented here suggest that the MPTP ± PEST/Grb2 interaction may play a role in growth factor receptor-mediated signal transduction events.
Results and discussion
The capacity of MPTP ± PEST to regulate tyrosine phosphorylation by virtue of its catalytic nature, its ability to bind to the adaptor protein SHC (Charest et al., 1996) and the presence of proline-rich sequences in the carboxyl terminus suggest potential role(s) for MPTP ± PEST in signal transduction events. These proline rich stretches may serve as binding sites for SH3 domains found in proteins involved in signalling cascades. In order to verify the ability of the prolinerich sequences within the MPTP ± PEST enzyme to act as SH3 binding sites, in vitro binding studies were conducted using a total of 11 GST-SH3 domain fusion proteins derived from dierent signalling molecules ( Figure 1a ). The SH3 domain of the viral oncoprotein v-Src and the full length SH3 ± SH2 ± SH3 adaptor protein Grb2 speci®cally bound to HA-MPTP ± PEST proteins in vitro (Figure 1a ). To corroborate these results under in vivo conditions, MPTP ± PEST immunoprecipitates from NIH3T3 cells were examined by immunoblot analysis for the presence of endogenous c-Src and Grb2 proteins. Immunoblotting of MPTP ± PEST immunoprecipitates using an anti-Src antibody failed to detect the presence of Src proteins (data not shown) suggesting that speci®c in vivo interactions between Src and MPTP ± PEST do not exist under these conditions. However, immunoreactive Grb2 proteins found in MPTP ± PEST immunoprecipitates using anti-Grb2 antibodies (Figure 1b and c) and the presence of immunoreactive MPTP ± PEST proteins in Grb2 immunoprecipitates (Figure 1d ) demonstrate that MPTP ± PEST interacts with Grb2 in vivo thus validating the results obtained from the GST fusion protein binding studies.
A series of GST fusion proteins derived from Grb2 ( Figure 2a and b) were generated in order to identify the necessary domain(s) (i.e. SH3 (N) , SH2, and SH3 (C) ) required for binding to MPTP ± PEST. Both SH3 domains (SH3 (N) and SH3 (C) ) but not the SH2 domain are capable of binding individually to recombinant puri®ed MPTP ± PEST proteins in vitro (Figure 2c ). Interestingly, GST fusion proteins containing both SH3 domains (i.e. Grb2-FL and SH3 (N) -SH3 (C) ), displayed a higher degree of binding to MPTP ± PEST. Similar synergistic binding have previously been reported for interactions described between Grb2 and Sos proteins (Yang et al., 1995b ). These results demonstrate that the adaptor molecule Grb2 associates with the tyrosine phosphatase MPTP ± PEST through either or both SH3 domains.
The binding preferences of both SH3 domains in relation to the ®ve proline-rich sequences of MPTP ± PEST (Pro 1 ± 5) was determined using GST fusion proteins containing each of the ®ve proline-rich domains (Figure 2d and e). These GST fusion proteins were subjected to protein overlay analysis using 32 Plabelled Grb2 SH3 (N) and SH3 (C) domains (Figure 2f and g, respectively) as probes. The results from the overlay assays demonstrate that the SH3 (N) domain preferentially binds to the GST-Pro 1 and GST-Pro 4 constructs. Interestingly, both Pro 1 (PPPKPPR) and Pro 4 (PPPLPER) sequences belong to class II SH3 domain binding consensus sequence (PXXPXR). The SH3 (N) domain of Grb2 has been shown to bind to proline-rich motifs belonging to class II consensus sequences such as those found on the hSos1 (PPPVPPR, PPAIPPR and PPLLPPR), hSos2 (PPPLPPR, PPPPPPR, PPPVPLR and APPVPPR) and Cbl (PPVPPPR) proteins Yang et al., 1995b) . Sequence comparison between these Grb2 SH3 (N) binding sites and MPTP ± PEST Pro 1 and Pro 4 reveals a high degree of identity (data not shown). The binding anities for each of these prolinerich sequences of MPTP ± PEST, hSos1-2 and Cbl need to be determined. The observation that these eector molecules bind to an adaptor protein via the same SH3 domain raises the possibility of competitive mechanisms thus creating additional regulatory processes.
The SH3 (C) domain of Grb2 preferentially binds to the GST-Pro 3, GST-Pro 4, and GST-Pro 5 constructs ( Figure 2g ). Pro 3 (PPRPDCLP) and Pro 5 (PKGPREPP) sequences do not conform to any canonical SH3 binding consensus sequences and therefore might represent novel SH3 binding motifs. Detailed mutagenic analyses of these sites could reveal variations on established SH3 binding sites. The fact that the SH3 domains of Grb2 bind to dierent subsets of proline-rich sequences on MPTP ± PEST (with the exception of Pro 4) suggests that both SH3 domains of a Grb2 molecule could simultaneously bind to dierent sites on MPTP ± PEST. This bipartite interacting phenomenon could in part be responsible for the synergistic binding eect observed when both SH3 domains are present on the same molecule ( Figure 2c) . A detailed three-dimensional structure analysis of the spatial orientations of the proline-rich sequences in relation to each other and to their binding SH3 domain counterparts is essential to study the molecular basis underlying such a synergistic eect.
The adaptor protein Grb2 links proteins containing phosphorylated tyrosine residues to proteins with proline-rich sequences via its SH2 and SH3 domains respectively. Grb2 has been shown to play an essential role in several signal transduction pathways including the activation of p21 ras by growth factor receptors (for review see Chardin et al., 1995) . The SH3 domainmediated Grb2/MPTP ± PEST complex may participate in growth factor receptor signalling cascades analogous to the p21 ras activation pathways. To test this hypothesis, in vivo reconstitution experiments were performed by transient co-expression of human EGF receptor, MPTP ± PEST, and dierent Grb2 proteins in 293 cells. MPTP ± PEST immunoprecipitates from dierent combinatorial transfections (Figure 3a and b) were analysed for the presence of activated EGF receptors by Western blot using an anti-phosphotyrosine antibody. Tyrosine phosphorylated EGF receptors were detected in MPTP ± PEST immunoprecipitates from wild type Grb2 co-transfectants. However, activated EGF receptors were not detected in control transfectants lacking Grb2 (Figure 3a, upper panel) suggesting that the presence of Grb2 is required for this in vivo interaction. The equivalent amounts of MPTP ± PEST/Grb2 protein complexes in both EGF treated and non-stimulated cells (Figure 3a , middle panel and 3b, second panel) suggest that this constitutive in vivo interaction does not seem to be modulated by EGF receptor activity.
Mutant Grb2 proteins (P49L, G203R and S90N) corresponding to the loss of function mutants alleles n1619, n2195 and n1781 of the Grb2 C. elegans homologue sem-5 protein (Clark et al., 1992) were used to determine the involvement of the SH3 domains (P49L and G203R) and of the SH2 domain (S90N) of Grb2 in the MPTP ± PEST/Grb2/EGF receptor complex. The SH3 domain mutants were expressed either individually or as a double mutant and analysed for their ability to mediate the binding of MPTP ± PEST to activated EGF receptors in the in vivo reconstitution assay system described above. The failure of all three Grb2 SH3 domain mutants (P49L, G203R and P49L/ G203R) to mediate this molecular interaction when compared to the wild type Grb2 protein (Figure 3a , upper panel) despite equivalent expression levels ( Figure 3a , lower panel) correlate with their reduced ability to interact with MPTP ± PEST proteins ( Figure  3a , middle panel). Control immunoblot analysis of cellular lysates using anti-EGF receptor and anti-MPTP ± PEST antibodies indicates identical amounts of EGF receptor and MPTP ± PEST proteins in each transfectant (data not shown). The low levels of bound G203R Grb2 mutant proteins remaining in the MPTP ± PEST immunoprecipitates (Figure 3a , upper panel) appear to be insucient in mediating a trimolecular interaction with activated EGF receptors in vivo. Threshold levels of MPTP ± PEST-bound Grb2 complexes may have to be attained in order for this trimolecular interaction to be detected. The low amounts of phosphorylated EGF receptors seen in the MPTP ± PEST immunoprecipitates of the mutant Grb2 transfectants may represent residual binding from the Grb2 mutants and/or by endogenous (i.e. wild type) Grb2 proteins and/or by SHC/MPTP ± PEST complexes (Charest et al., 1996) .
The presence of a functional SH2 domain in Grb2 has been shown to be an essential component in the recruitment of Grb2/SOS complexes to activated growth factor receptors (McCormick, 1993) . To ascertain the involvement of the SH2 domain of Grb2 in the MPTP ± PEST/Grb2/EGF receptor complex, a mutant Grb2 protein with a de®cient SH2 domain (mutation S90N, Stern et al., 1993) was used in transient co-expression studies. Figure 3b demonstrates that the mutant Grb2 protein, when compared to its wild type counterpart, is incapable of mediating this tri-molecular interaction (Figure 3b . The dierent GST-Pro-rich fusion proteins represented in (d and e) were separated on SDS ± PAGE, transferred to nitrocellulose membranes and probed with puri®ed 32 P-labelled NH 2 -terminus (f, SH3 (N) ) or COOH-terminus (g,SH3 (C) ) SH3 domains of Grb2 as described under Materials and methods' EGF stimulated cells expressing the human EGF receptor (HER14) (Honegger et al., 1987) for the presence of activated EGF receptors. MPTP ± PEST immunoprecipitates analysed by immunoblot analysis using either anti-phosphotyrosine (Figure 3c , left panel) or anti-human EGF receptor (Figure 3c , right panel) antibodies reveal the presence of activated EGF receptors and that this phenomenon is dependent on tyrosine phosphorylation of the receptor. The Grb2 SH3 domain-mediated recruitment of cytoplasmic MPTP ± PEST to membrane-bound EGF receptors might serve to relocalize the MPTP ± PEST enzyme where it could ful®l its function by acting upon its substrate(s). In an attempt to identify substrate(s) of MPTP ± PEST we exploited the observation that mutation of the conserved catalytically essential cysteine residue to a serine renders tyrosine phosphatases inactive but still permits substrate binding (Milarski et al., 1993) . This mutation maintains the three-dimensional structure of the catalytic domain (Jia et al., 1995) and allows for the trapping and identi®cation of potential substrate(s). A mutated MPTP ± PEST C231S was expressed as a bacterial GST fusion protein (aa 1 ± 453) which comprises the catalytic domain of MPTP ± PEST (Charest et al., 1995b) and used in in vitro binding experiments to speci®cally detect tyrosine phosphorylated substrate(s) of MPTP ± PEST.
Anity puri®ed MPTP ± PEST C231S and its wild type (WT) counterpart were incubated with cell lysates derived from quiescent (7EGF) or EGF stimulated (+EGF) HER14 cells. The protein complexes were then subjected to Western blot analysis using antiphosphotyrosine antibodies. A single tyrosine phosphorylated protein migrating on an SDS ± PAGE with an apparent molecular weight of approximately 120 kDa (herein referred to as pp120) is speci®cally recognized by the mutant MPTP ± PEST C231S protein (Figure 4) . Phosphorylation of the p120 is dependent on stimulation of the cells with EGF. This tyrosine phosphorylation event could be the result of a direct kinase activity of the EGF receptor on the p120 or simply represents secondary phosphorylation events triggered by EGF receptor stimulation. This in vitro assay does not distinguish between these two possible mechanisms of action. Binding of this pp120 to MPTP ± PEST C231S proteins could conceivably be the result of a substrate-independent protein-protein association where the MPTP ± PEST C231S -bound p120 would remain phosphorylated given the inactive state of the enzyme. To address this issue, an inactive splice variant deletion of the MPTP ± PEST enzyme lacking amino acids 141 ± 164 which is the result of exon VI (Charest et al., 1995a) being spliced out (Charest and Tremblay, unpublished results) was used in similar trapping experiments. This mutant MPTP ± PEST protein was unable to interact with the phosphorylated p120 (data not shown) suggesting that the p120 is not a tyrosine phosphorylated protein associated to MPTP ± PEST but rather is a genuine substrate for MPTP ± PEST.
To determine the identity of the pp120, several antibodies directed against candidate proteins exhibiting a similar size and phosphorylation pro®le to this pp120 were tested by Western blot analysis. Antibodies directed against p120
RasGAP (Serth et al., 1992) , p120
cbl , Gab-1 (Holgado-Madruga et al., 1996) and pp120 (a v-Src substrate) (Reynolds et al., 1994) failed to recognize pp120 suggesting that it does not correspond to any of the proteins tested (data not shown). Additional experiments indicate that this pp120 is not MPTP ± PEST (data not shown) despite the close similarity in size. The identi®cation of this p120 substrate in addition to the function(s) arising from its tyrosine phosphorylation levels represent Her14 cells were incubated with puri®ed wild type (WT) or cysteine 231 to serine mutant (C231S) GST ± PEST-1-453aa fusion proteins. Tyrosine phosphorylated proteins recognized by the catalytic domain of MPTP ± PEST were detected by Western blot analysis using an anti-phosphotyrosine antibody. Twenty-®ve mg of total cell lysates (TCL) were used to control for the level of tyrosine phosphorylation in the protein extracts Figure 5 Molecular model of the function of MPTP ± PEST. Speci®c SH3-mediated interactions between the adaptor molecule Grb2 and proline-rich sequences of the tyrosine phosphatase MPTP ± PEST allows for the recruitment of MPTP ± PEST to the activated EGF receptor. This may result in a relocalization phenomenon whereby MPTP ± PEST is recruited towards a potential substrate of 120 kDa (p120) which becomes tyrosine phosphorylated upon EGF stimulation of cells SH3 domain-mediated binding of Grb2 to MPTP ± PEST A Charest et al essential elements in determining crucial aspects of MPTP ± PEST function at the molecular level.
The results described here enable the formulation of a model ( Figure 5 ) whereby the MPTP ± PEST enzyme, by virtue of its constitutive association with the adaptor molecule Grb2 through an SH3-proline-rich domain interaction, can form molecular complexes with activated EGF receptors. This interaction occurs via the SH2 domain of bound Grb2 to phosphorylated tyrosine residues on the EGF receptor (Figure 3b ). This complex can be the result of a direct trimolecular interaction (MPTP ± PEST/Grb2/EGF receptor) or could be mediated by other yet unidenti®ed component(s). In either case, autophosphorylation of the activated EGF receptor and the presence of a functional Grb2 SH2 domain are essential for the formation of the complex. The potential mobilization of MPTP ± PEST proteins towards activated EGF receptors might serve to bring MPTP ± PEST in close proximity to the pp120 substrate which is itself dependent on EGF for its phosphorylation. The consequences of this functional recruitment may reside in downstream events triggered by the modulation of tyrosine phosphorylation of the p120.
Other previously characterized interactions between cytoplasmic protein tyrosine phosphatases and activated growth factor receptors include the SH2-containing tyrosine phosphatases SHP-1 (also known as SHPTP-1, SHP, HCP, and PTP1C) and SHP-2 (also referred to as SHPTP-2, SHPTP-3, Syp, PTP-2C, and PTP1D). The ubiquitously expressed SHP-2 has been shown to directly bind via its SH2 domains to the phosphorylated EGF and PDGF receptor tyrosine kinases Lechleider et al., 1993; Vogel et al., 1993) as well as to the Tpr-Met oncoprotein (Fixman et al., 1996) and the insulin signalling docking protein IRS-1 (Kuhne et al., 1993) . Conversely, the hematopoietic speci®c SHP-1 interacts with the phosphorylated c-Kit and erythropoietin receptors (Klingmuller et al., 1995) in addition to the IL-3 b chain . The presence of these PTPases in phosphotyrosine signalling events ascribes a regulatory function for these enzymes. Here we show that another cytoplasmic protein tyrosine phosphatase, MPTP ± PEST, can indirectly associate to the activated EGF receptor via a novel SH3 domain-mediated binding to Grb2 thus potentially attributing analogous regulatory functions to MPTP ± PEST in signalling cascades.
The bimolecular and modular interaction of Grb2 and MPTP ± PEST may represent a prototype mechanism of recruitment given the ubiquitous pattern of expression of both of these proteins. Tissue speci®c related members of each of these components may participate interchangeably in similar interactions thereby conferring tissue and/or induction speci®city by exposing such complexes to specialized tyrosine kinases and/or signalling cascades. For example, the closely related hematopoietic-speci®c PTP ± PEP (Matthews et al., 1992) and the more distant brain-speci®c striatum enriched PTPase STEP (Li et al., 1995) also contain several putative SH3 binding sites. The hematopoietic speci®c SH3 ± SH2 ± SH3 adaptor Grap1 protein (Feng et al., 1996) together with these PTPases may participate in the regulation of signalling events via similar SH3 domain-mediated interactions.
The presence of the MPTP ± PEST enzyme in phosphotyrosine-mediated signalling cascades represents a new regulatory component involved in these events. The work presented here assigns a role for MPTP ± PEST in the context of EGF-mediated signalling events. The identi®cation of pp120 and the regulation of its phosphorylation status may reveal an additional function of MPTP ± PEST as a key mediator in signalling cascades involving the EGF receptor tyrosine kinase and the adaptor molecule Grb2.
Materials and methods
Cell culture and transient transfections NIH3T3, COS-1, 293, and HER14 cells were maintained in Dulbecco's modi®ed Eagle's medium supplemented with 10% fetal bovine serum and antibiotics. Sf9 cells were maintained at 258C in complete Grace's insect cell medium (Gibco-BRL) supplemented with 10% fetal bovine serum and antibiotics. Electroporation of COS-1 cells was performed as previously described (Charest et al., 1995b) . 293 cells were transiently transfected using the calcium phosphate coprecipitation method (Sambrook et al., 1989) using 50 mg/mL of plasmid DNA. Forty-eight hours posttransfection, cellular proteins were harvested in HNMETG binding buer (50 mM HEPES, pH 7.5, 150 mM NaCl, 1.5 mM MgCl 2 , 1 mM EGTA pH 8.0, 1% Triton X-100, 10% Glycerol) supplemented with protease and phosphatase inhibitors and analysed by Western blot and/or immunoprecipitation as described.
Recombinant proteins, binding studies and protein overlay (farwestern) assays
The GST fusion proteins described herein were prepared from their respective cDNAs by polymerase chain reaction (PCR) using oligonucleotide primers¯anking the appropriate domain boundaries. Mutation of the catalytically essential cysteine residue (Cys231) of MPTP ± PEST to a serine residue in a GST fusion protein consisting of the catalytic domain of MPTP ± PEST (GST-PEST-1 ± 453aa) was generated by PCR. The recombinant polyhistidine HA-tagged MPTP ± PEST protein (66His-HA-MPTP ± PEST) was constructed in the baculovirus transfer vector pP10 (Vialard et al., 1990) using standard recombinant DNA technology. Recombinant baculoviruses were then generated using a linear AcMNPV DNA Transfection Module (Invitrogen) and used to infect Sf9 insect cells. Cells were harvested 4 days after infection and the 66His-HA-MPTP ± PEST recombinant proteins were anity puri®ed from cell lysates on a Ni 2+ ± NTA-agarose column (Qiagen) according to previously described protocols (Amarneh and Simpson, 1995; Horstman et al., 1995) . GST fusion proteins derived from the pGEX-2TK vector were expressed in E. coli and anity puri®ed on glutathione-Sepharose beads (Pharmacia Biotech Inc.) according to established protocols (Ausubel et al., 1995) . The puri®ed GST ± SH3 domains (NH 2 -and COOH-) of Grb2 were labelled with [g-32 P]ATP (NEN) using protein kinase A (Sigma) according to the manufacturer's protocol and thrombin cleaved to remove the GST moiety. Protein concentration and in vitro binding studies using GST fusion proteins were performed as described elsewhere (Charest et al., 1996) . Overlay assays using 32 P-labelled Grb2 SH3 domains as probes were performed according to established protocols (Yang et al., 1995a) .
Antibodies, immunoprecipitation and immunoblotting
The anti-human Grb2, the anti-human EGF receptor LA22 (Upstate Biotechnology Inc.), the anti-Phosphotyrosine PY20, and the anti-human EGF receptor L2 (Transduction Laboratories) are monoclonal antibodies. The anti-human Grb2 C-23 (Santa Cruz Biotechnology) is a polyclonal antibody. The rabbit anti-MPTP ± PEST polyclonal and the anti-HA tag monoclonal antibodies have been described elsewhere (Charest et al., 1995b) . These antibodies were used for immunoprecipitation and immunoblotting procedures as described in the ®gure legends.
Abbreviations SH3, Src homology 3; GST, glutathione S-transferase; EGF, epidermal growth factor; TCL, total cell lysate; Grb2, growth factor receptor-binding protein 2; HA, heamagglutinin antigen; PTPase, protein tyrosine phosphatases; Sos, Son of sevenless.
Note added in proof
Recently, p130 cas has been identi®ed as a substrate for the human PTP ± PEST enzyme: Identi®cation of p130 cas as a substrate for the cytosolic protein tyrosine phosphatase PTP ± PEST. Andrew J Garton, Andrew J Flint, and Nicholas K Tonks. Mol. Cell Biol., 16, 6408 ± 6418. (1996) .
